Valvular Heart Disease

View Sample PDF

Author(s): Christine M. Lennon (Weill Cornell Medical Center, USA), Alexander C. P. Fort (Weill Cornell Medical Center, USA)and Shawn Hansberry (Weill Cornell Medical Center, USA)
Copyright: 2015
Pages: 48
Source title: Modern Concepts and Practices in Cardiothoracic Critical Care
Source Author(s)/Editor(s): Adam S. Evans (Icahn School of Medicine at Mount Sinai, USA), Gregory E. Kerr (Weill Cornell Medical College, USA), Insung Chung (Icahn School of Medicine at Mount Sinai, USA)and Robin Varghese (Icahn School of Medicine at Mount Sinai, USA)
DOI: 10.4018/978-1-4666-8603-8.ch008

Keywords: Cardiovascular Medicine / Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare

Purchase

View Valvular Heart Disease on the publisher's website for pricing and purchasing information.

Abstract

Valvular heart disease is a common cardiovascular disorder, with an estimated prevalence of 2.5% in the United States. The disease is particularly burdensome in adults over 75 years of age, with 13.3% having moderate to severe disease of the aortic or mitral valve. As populations grow older, diagnostic capabilities improve, and health care becomes more accessible, the number of patients with valvular heart disease undergoing both cardiac and non-cardiac surgery will continue to grow. The preoperative assessment and optimization of these patients is a complex task involving multiple specialists, including internists, cardiologists, intensivists, cardiothoracic surgeons, and anesthesiologists. As newer therapeutic options are offered to patients with numerous comorbidities, the preoperative management of these patients will require a sophisticated multimodal approach. The purpose of this chapter is to summarize the preoperative assessment and optimization of patients with valvular heart disease undergoing cardiac and non-cardiac surgery.

The IRMA Community

Research IRM

Valvular Heart Disease

Purchase

Abstract

Related Content

IRMA Sponsors